Relay Therapeutics Statistics
Total Valuation
RLAY has a market cap or net worth of $576.06 million. The enterprise value is -$87.14 million.
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, after market close.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
RLAY has 171.44 million shares outstanding. The number of shares has increased by 22.01% in one year.
| Current Share Class | 171.44M |
| Shares Outstanding | 171.44M |
| Shares Change (YoY) | +22.01% |
| Shares Change (QoQ) | +1.13% |
| Owned by Insiders (%) | 2.03% |
| Owned by Institutions (%) | 70.62% |
| Float | 110.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 66.71 |
| Forward PS | 134.37 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.96, with a Debt / Equity ratio of 0.07.
| Current Ratio | 19.96 |
| Quick Ratio | 19.17 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.46% and return on invested capital (ROIC) is -30.19%.
| Return on Equity (ROE) | -45.46% |
| Return on Assets (ROA) | -28.82% |
| Return on Invested Capital (ROIC) | -30.19% |
| Return on Capital Employed (ROCE) | -49.63% |
| Revenue Per Employee | $29,421 |
| Profits Per Employee | -$1.28M |
| Employee Count | 261 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.61% in the last 52 weeks. The beta is 1.59, so RLAY's price volatility has been higher than the market average.
| Beta (5Y) | 1.59 |
| 52-Week Price Change | -52.61% |
| 50-Day Moving Average | 3.00 |
| 200-Day Moving Average | 4.50 |
| Relative Strength Index (RSI) | 55.99 |
| Average Volume (20 Days) | 1,527,824 |
Short Selling Information
The latest short interest is 22.65 million, so 13.21% of the outstanding shares have been sold short.
| Short Interest | 22.65M |
| Short Previous Month | 23.16M |
| Short % of Shares Out | 13.21% |
| Short % of Float | 20.58% |
| Short Ratio (days to cover) | 10.01 |
Income Statement
In the last 12 months, RLAY had revenue of $7.68 million and -$333.39 million in losses. Loss per share was -$2.19.
| Revenue | 7.68M |
| Gross Profit | -299.17M |
| Operating Income | -378.35M |
| Pretax Income | -322.83M |
| Net Income | -333.39M |
| EBITDA | -373.07M |
| EBIT | -378.35M |
| Loss Per Share | -$2.19 |
Full Income StatementBalance Sheet
The company has $710.36 million in cash and $47.16 million in debt, giving a net cash position of $663.20 million or $3.87 per share.
| Cash & Cash Equivalents | 710.36M |
| Total Debt | 47.16M |
| Net Cash | 663.20M |
| Net Cash Per Share | $3.87 |
| Equity (Book Value) | 721.08M |
| Book Value Per Share | 4.23 |
| Working Capital | 702.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$271.99 million and capital expenditures -$622,000, giving a free cash flow of -$272.62 million.
| Operating Cash Flow | -271.99M |
| Capital Expenditures | -622,000 |
| Free Cash Flow | -272.62M |
| FCF Per Share | -$1.59 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -4,927.05% |
| Pretax Margin | -4,341.53% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.01% |
| Shareholder Yield | -22.01% |
| Earnings Yield | -57.87% |
| FCF Yield | -47.32% |
Dividend DetailsAnalyst Forecast
The average price target for RLAY is $18.40, which is 447.62% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.40 |
| Price Target Difference | 447.62% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 73.58% |
| EPS Growth Forecast (5Y) | -17.79% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RLAY has an Altman Z-Score of 3.06 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.06 |
| Piotroski F-Score | 1 |